Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy
暂无分享,去创建一个
S. Landolfo | F. Prodam | M. Vecchi | M. Gariglio | M. De Andrea | L. Pastorelli | R. Boldorini | D. Roggenbuck | L. Pisani | Barbara Bruni | V. Caneparo